TRI-LINYAH Drug Patent Profile
✉ Email this page to a colleague
When do Tri-linyah patents expire, and what generic alternatives are available?
Tri-linyah is a drug marketed by Novast Labs Ltd and is included in one NDA.
The generic ingredient in TRI-LINYAH is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
Summary for TRI-LINYAH
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Patent Applications: | 8 |
Formulation / Manufacturing: | see details |
Drug Sales Revenues: | Drug sales revenues for TRI-LINYAH |
DailyMed Link: | TRI-LINYAH at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRI-LINYAH
US Patents and Regulatory Information for TRI-LINYAH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs Ltd | TRI-LINYAH | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090524-001 | May 30, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |